Related Experiment Videos
Dynamic cardiomyoplasty in patients with end-stage heart failure: anaesthetic considerations
1Department of Anaesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Germany.
Insights
Dynamic cardiomyoplasty augments heart function in chronic heart failure patients. Early inotropic agent use is crucial for managing patients with severely impaired left ventricular function.
Area of Science:
- Cardiovascular Surgery
- Cardiac Electrophysiology
- Anesthesiology
Background:
- Dynamic cardiomyoplasty (DCM) is an emerging surgical option for end-stage heart failure.
- This procedure involves wrapping a vascularized latissimus dorsi muscle flap around the heart.
- The muscle is stimulated to augment cardiac function synchronously with ventricular systole.
Observation:
- This study details the anesthetic management of 22 patients with severe chronic heart failure (NYHA III-IV) undergoing DCM.
- The primary challenge lies in managing patients with significantly impaired left ventricular function who may not show immediate operative benefits.
- Two case reports are included to illustrate specific patient scenarios.
Findings:
- The anesthetic approach must address the complexities of severely compromised cardiac function.
- Close monitoring and management of hemodynamics are essential throughout the perioperative period.
- The study highlights the critical role of the anesthesiologist in optimizing patient condition for DCM.
Implications:
- Effective anesthetic management is vital for successful dynamic cardiomyoplasty outcomes.
- Early administration of inotropic agents is strongly supported by this experience.
- This approach offers a potential therapeutic avenue for select patients with advanced heart failure.
Abstract:
Dynamic cardiomyoplasty is used increasingly for patients with chronic heart failure, with approximately 500 cases having been performed. The latissimus dorsi muscle is prepared maintaining its vascular supply and the muscle flap is wrapped around the heart and connected to a cardiomyostimulator. The muscle is later stimulated synchronously with ventricular systole to augment the heart. Our experience of 22 patients with chronic heart failure (NYHA III-IV) undergoing dynamic cardiomyoplasty is described from the anaesthetist's point of view. Two patients are reported as case reports. The challenge is to manage patients with severely impaired left ventricular function, who do not obtain immediate benefit from the operation. Our experience supports the importance of early use of inotropic agents.